ReviewOncoTargets and therapy2021

Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy.

Huixian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.